Cargando…

Longitudinal Effects of Metabolic Syndrome on Alzheimer and Vascular Related Brain Pathology

BACKGROUND/AIMS: This study examines the longitudinal effect of metabolic syndrome (MetS) on brain-aging indices among cognitively normal (CN) and amnestic mild cognitive impairment (aMCI) groups [single-domain aMCI (saMCI) and multiple-domain aMCI (maMCI)]. METHODS: The study population included 73...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Feng, Lo, Raymond Y., Cole, Daniel, Ducharme, Simon, Chen, Ding-Geng, Mapstone, Mark, Porsteinsson, Anton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2014
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187257/ https://www.ncbi.nlm.nih.gov/pubmed/25337075 http://dx.doi.org/10.1159/000363285

Ejemplares similares

Temporospatial components of brain ERPs as biomarkers for Alzheimer's disease
por: Chapman, Robert M., et al.
Publicado: (2018)

Novel Therapeutics in Alzheimer's Disease
por: Sabbagh, Marwan, et al.
Publicado: (2012)

Cognitively supernormal older adults maintain a unique structural connectome that is resistant to Alzheimer’s pathology
por: Chen, Quanjing, et al.
Publicado: (2020)

The Brain NGF Metabolic Pathway in Health and in Alzheimer’s Pathology
por: Cuello, A. Claudio, et al.
Publicado: (2019)

Women's higher brain metabolic rate compensates for early Alzheimer's pathology
por: Sundermann, Erin E., et al.
Publicado: (2020)

Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndrome
por: Mapstone, Mark, et al.
Publicado: (2020)

Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers
por: Janelidze, Shorena, et al.
Publicado: (2022)

Longitudinal Analysis of the Microbiome and Metabolome in the 5xfAD Mouse Model of Alzheimer’s Disease
por: Dunham, Sage J. B., et al.
Publicado: (2022)

Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval
por: Tolar, Martin, et al.
Publicado: (2020)

Imaging Brain Metabolism and Pathology in Alzheimer’s Disease with Positron Emission Tomography
por: Shokouhi, S, et al.
Publicado: (2014)

Brain amyloid burden, sleep, and 24-hour rest/activity rhythms: screening findings from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration Studies
por: Spira, Adam P, et al.
Publicado: (2021)

Metabolic and Vascular Imaging Biomarkers in Down Syndrome Provide Unique Insights Into Brain Aging and Alzheimer Disease Pathogenesis
por: Head, Elizabeth, et al.
Publicado: (2018)

Alzheimer's Disease Amyloid-β Links Lens and Brain Pathology in Down Syndrome
por: Moncaster, Juliet A., et al.
Publicado: (2010)

Clinico‐pathological comparison of patients with autopsy‐confirmed Alzheimer's disease, dementia with Lewy bodies, and mixed pathology
por: Chatterjee, Atri, et al.
Publicado: (2021)

Contribution of blood platelets to vascular pathology in Alzheimer’s disease
por: Zhang, Wei, et al.
Publicado: (2013)

Clinical and imaging features of mixed Alzheimer and vascular pathologies
por: Chui, Helena C, et al.
Publicado: (2015)

Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia
por: Marino, Silvia, et al.
Publicado: (2019)

Vascular pathology in the aged human brain
por: Grinberg, Lea Tenenholz, et al.
Publicado: (2010)

Effects of Alzheimer’s and Vascular Pathologies on Structural Connectivity in Early- and Late-Onset Alzheimer’s Disease
por: Lee, Wha Jin, et al.
Publicado: (2021)

Age‐stratified longitudinal study of Alzheimer's and vascular dementia patients
por: Jørgensen, Isabella Friis, et al.
Publicado: (2020)

Clinicopathological correlation of psychosis and brain vascular changes in Alzheimer’s disease
por: Ting, Simon Kang Seng, et al.
Publicado: (2016)

Alzheimer and vascular brain disease: Senile dementia
por: Engelhardt, Eliasz, et al.
Publicado: (2015)

Metabolic Syndrome and Risk for Incident Alzheimer's Disease or Vascular Dementia: The Three-City Study
por: Raffaitin, Christelle, et al.
Publicado: (2009)

Diagnostic Imaging Fundamentals: Brain Vascular Pathology
por: Xia, Erwin, et al.
Publicado: (2017)

Alois Alzheimer and vascular brain disease: Arteriosclerotic atrophy of the brain
por: Engelhardt, Eliasz, et al.
Publicado: (2015)

Neuroimaging Biomarkers of mTOR Inhibition on Vascular and Metabolic Functions in Aging Brain and Alzheimer’s Disease
por: Lee, Jennifer, et al.
Publicado: (2018)

The overlap between vascular disease and Alzheimer’s disease - lessons from pathology
por: Attems, Johannes, et al.
Publicado: (2014)

Cerebrovascular pathology in Down syndrome and Alzheimer disease
por: Head, Elizabeth, et al.
Publicado: (2017)

Differentiation of Alzheimer's disease based on local and global parameters in personalized Virtual Brain models
por: Zimmermann, J., et al.
Publicado: (2018)

Alzheimer and vascular brain diseases: Focal and diffuse subforms
por: Engelhardt, Eliasz, et al.
Publicado: (2015)

Longitudinal brain activity changes in asymptomatic Alzheimer disease
por: Codispoti, Kari-Elise T, et al.
Publicado: (2012)

The pathological role of vascular aging in cardio-metabolic disorder
por: Katsuumi, Goro, et al.
Publicado: (2016)

Vascular Dysfunction in Alzheimer’s Disease: A Prelude to the Pathological Process or a Consequence of It?
por: Govindpani, Karan, et al.
Publicado: (2019)

Age, vascular disease, and Alzheimer’s disease pathologies in amyloid negative elderly adults
por: Guo, Tengfei, et al.
Publicado: (2021)

Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
por: Chen, Shi-Dong, et al.
Publicado: (2021)

APOE ε4/ε4 homozygotes with early Alzheimer's disease show accelerated hippocampal atrophy and cortical thinning that correlates with cognitive decline
por: Abushakra, Susan, et al.
Publicado: (2020)

Age-related reduction in brain ACE-2 is not exacerbated by Alzheimer’s disease pathology in mouse models of Alzheimer’s disease
por: MacLachlan, Robert, et al.
Publicado: (2022)

Metabolic profiling of Alzheimer's disease brains
por: Inoue, Koichi, et al.
Publicado: (2013)

Brain Metabolic Alterations in Alzheimer’s Disease
por: Ardanaz, Carlos G., et al.
Publicado: (2022)

Alzheimer’s pathology is associated with altered cognition, brain volume, and plasma biomarker patterns in traumatic encephalopathy syndrome
por: Asken, Breton M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jubggteop6013pvsbpim3mbds4